Novel platinum-based anticancer drug: a complete vibrational study.

Area of Science:

• Coordination Chemistry
• Materials Science
• Computational Chemistry

Background:

• Cisplatin's introduction revolutionized cancer treatment, spurring the search for new metal-based drugs.
• Polynuclear platinum(II) and palladium(II) complexes with bridging ligands are promising anticancer agents.
• These complexes exhibit cytotoxicity against aggressive cancers like metastatic breast adenocarcinoma and osteosarcoma.

Purpose of the Study:

• To analyze the structure and vibrational properties of the platinum(II) complex [Pt₂Cl₄(C₁₀H₂₆N₄)], denoted Pt₂Spm.
• To correlate experimental spectroscopic data with theoretical calculations for accurate molecular representation.
• To investigate the potential of Pt₂Spm as an anticancer agent by assessing its DNA crosslinking capabilities.

Main Methods:

• Vibrational spectroscopy, including Raman, FT-IR, and Inelastic Neutron Scattering (INS).
• Theoretical calculations using Density Functional Theory (DFT) and Effective Core Potential (ECP) methods.
• Solid-state geometry analysis and vibrational mode assignment.

Main Results:

• The solid-state geometry of Pt₂Spm was determined to have Cᵢ symmetry with 132 vibrational modes.
• INS and Raman spectroscopy provided complementary data, enabling unambiguous assignment of vibrational modes, including Pt-N stretching frequencies.
• Calculated metal-to-metal distances suggest Pt₂Spm can form effective inter- and intrastrand crosslinks with DNA.

Conclusions:

• The study successfully assigned the vibrational profile of Pt₂Spm, validating its structure and properties.
• The findings support Pt₂Spm's potential as an anticancer agent due to its DNA crosslinking ability.
• This research contributes to understanding the molecular mechanism of Pt₂Spm, aiding the development of superior chemotherapy drugs.